Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03857919 · ClinicalTrials.gov registry record · NA
TearCare System to Treat Dry Eye Disease
A NA study, sponsored by Sight Sciences.
- Completed
- Registry status
- NA
- Development phase
- 235
- Enrollment target
NCT03857919: Completed NA study, sponsored by Sight Sciences.
NCT03857919 is a NA study that has completed, run by Sight Sciences. The registered enrollment target is 235 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03857919, a NA study, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
Study Summary
In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.
Primary Outcome
Tear Break-Up Time is the time measured to the first observation of a break in the tear film
Interventions
- DEVICE TearCare
- DEVICE LipiFlow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2019-03-03 |
| Est. Completion | 2020-12-18 |
| Phase | NA |
What the finished NCT03857919 record still lists
NCT03857919 is an interventional study that assigns participants to a tested intervention. The registered 235 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which TearCare is the first listed.
NCT03857919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03857919 about?
NCT03857919 is a clinical study titled "TearCare System to Treat Dry Eye Disease". In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.
What is the current status of trial NCT03857919?
This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 2019-03-03. Estimated completion is 2020-12-18.
What interventions are being tested in trial NCT03857919?
The interventions under investigation include: TearCare (DEVICE), LipiFlow (DEVICE).
Who is sponsoring clinical trial NCT03857919?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03857919's enrollment target sits among peer trials
235 461st of 2000 higher than 1,539 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01524211 · 235 participants · NA
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
- NCT05316155 · 235 participants · Phase 1
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- NCT05353569 · 235 participants · NA
Coherent Optical Detection of Middle Ear Disease
- NCT05390918 · 235 participants · NA
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI